✦ LIBER ✦

Severe skeletal muscle damage following the administration of mesalazine to a patient with ulcerative colitis

✍ Scribed by Nobutada Tabata; Keisuke Sugimoto; Satoshi Ueda; Naoki Sakata; Mitsuru Okada; Toshiharu Miyake; Tohru Shinohara; Makoto Yagi; Takao Satou; Tsukasa Takemura

Book ID: 108972814
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 39 KB
Volume: 51
Category: Article
ISSN: 1328-8067
DOI: 10.1111/j.1442-200x.2009.02935.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Skeletal muscle disorders associated wit

Skeletal muscle disorders associated with inflammatory bowel diseases: occurrence of myositis in a patient with ulcerative colitis and Hashimoto's thyroiditis—case report and review of the literature

✍ Omero Alessandro Paoluzi; Pietro Crispino; Margherita Rivera; Federico Iacopini; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 96 KB

MMX Multi Matrix System® mesalazine for

MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

✍ W. J. SANDBORN; M. A. KAMM; G. R. LICHTENSTEIN; A. LYNE; T. BUTLER; R. E. JOSEPH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

W1234 A Prospective Follow-Up Study to A

W1234 A Prospective Follow-Up Study to Assess the Long-Term Efficacy of Leukocytapheresis in Patients with Steroid Refractory Ulcerative Colitis

✍ Fukunaga, Ken; Ohnishi, Kunio; Hida, Nobuyuki; Ohda, Yoshio; Tozawa, Katsuyuki; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 103 KB

A Randomized, Multicenter, Open-Label Ph

A Randomized, Multicenter, Open-Label Phase 3 Study to Evaluate the Safety and Efficacy of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis

✍ Jeffrey S. Hyams; Lakshmi Damaraju; Marion Blank; Jewel Johanns; Cynthia Guzzo; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 519 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB